Page 10 - திரு பி.எம் பாட்டீல் நிறுவனம் ஆஃப் நர்சிங் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from திரு பி.எம் பாட்டீல் நிறுவனம் ஆஃப் நர்சிங் அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In திரு பி.எம் பாட்டீல் நிறுவனம் ஆஃப் நர்சிங் அறிவியல் Today - Breaking & Trending Today

UPMC spins out AI-driven analytics company focused on chronic disease patients

Realyze Intelligence, incubated at and funded by UPMC Enterprises, provides a platform that uses EMR data to identify chronic disease patients and help clinicians link them to appropriate treatment options. The platform leverages not only the structured data available in EMRs but also unstructured clinical notes. ....

Oscarc Marroquin , Aaron Brauser , Gilan El Saadawi , Realyze Intelligence , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness , Mployee Wellness Programs , Hanghai Innovation Center , R D ,

Vincerx Pharma Announces First Patient Dosed in Phase 1b Study of VIP152 in MYC-Driven Relapsed or Refractory Aggressive Lymphomas and Advanced Solid Tumors

First patient dosed by Vincerx marks significant milestone in Company’s developmentPALO ALTO, Calif., June 03, 2021 (GLOBE NEWSWIRE) Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that the first patient has been dosed in the Company’s Phase 1b study of VIP152 in MYC-driven relapsed or refractory (R/R) aggressive lymphomas and advanced solid tumors. “Vin ....

Vincerx Pharma , Vincerx Pharma , Iopharmaceutical Company , Pancreatic Cancer , Dose Escalation Study , Forward Looking Statements , Ovarian Cancer , Triple Negative Breast Cancer , Clinical Activity , Salivary Gland Cancer ,

GAO: FCC Needs a More Clarified Role in Disaster Response


GAO: FCC Needs a More Clarified Role in Disaster Response
Tuesday, June 01, 2021 | Comments
The Government Accountability Office (GAO) found that while the FCC took actions to support telecommunications restoration following Hurricane Maria, future disaster recovery efforts could be improved by identifying a clearer role for the agency in disaster response.
During Hurricane Maria, the FCC collected network outage information, provided staff assistance to Puerto Rico, created the Hurricane Recovery Task Force to support communications restoration in Puerto Rico and the U.S. Virgin Islands (USVI), and made funds for network restoration available.
“However, GAO found that FCC s disaster response role was unclear in guidance published by the Department of Homeland Security (DHS), even though the guidance states that all levels of government should understand their respective roles,” GAO’s report said. “In particular, DHS did not define specific a ....

Puerto Rico , Department Of Homeland Security , Government Accountability Office , Hurricane Recovery Task , Hurricane Maria , Hurricane Recovery Task Force , Homeland Security , Recovery Task Force , Mission Critical , Radioresource International , Radio Resource , Public Safety Communications , Two Way Radio , Fcc Rules , Policy Rf Coverage , Analog Radio , Digital Mobile Radio , Project 25 , Mpt 1327 1343 , Multi Band Radio Emergency Communications , Ng9 1 , Public Safety Answering Points , Microwave Backhaul , Interoperable Gateways , Mission Critical Communications Network , Data Devices ,